Amended Statement of Ownership (sc 13g/a)
February 10 2022 - 4:17PM
Edgar (US Regulatory)
United States
Securities and Exchange Commission
Washington, D.C. 20549
Schedule 13G
(Rule 13d-102)
Information to be Included in Statements Filed Pursuant
to § 240.13d-1(b), (c) and (d) and Amendments Thereto Filed
Pursuant to § 240.13d-2
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 1)*
Atea
Pharmaceuticals, Inc.
(Name of Issuer)
Common Stock, par value $0.001
(Title of Class of Securities)
04683R106
(CUSIP Number)
December 31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to
designate the rule pursuant to which this Schedule is filed:
*
|
The remainder of this cover page shall be filled out for a reporting persons initial filing on this form
with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
|
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities
Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
|
|
|
|
CUSIP No. 04683R106
|
|
Schedule 13G
|
|
Page 1 of 6
|
|
|
|
|
|
|
|
1
|
|
Names of Reporting Persons
JPM Partners LLC
|
2
|
|
Check the Appropriate Box
if a Member of a Group
(a) ☐ (b) ☐
|
3
|
|
SEC Use Only
|
4
|
|
Citizenship or Place of
Organization
Delaware
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
5
|
|
Sole Voting Power
0
|
|
6
|
|
Shared Voting Power
5,925,000
|
|
7
|
|
Sole Dispositive Power
0
|
|
8
|
|
Shared Dispositive Power
5,925,000
|
|
|
|
|
|
|
|
9
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
5,925,000
|
10
|
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares
Not
Applicable
|
11
|
|
Percent of Class
Represented by Amount in Row 9
7.2%
|
12
|
|
Type of Reporting
Person
OO (Limited Liability Company)
|
|
|
|
|
|
CUSIP No. 04683R106
|
|
Schedule 13G
|
|
Page 2 of 6
|
|
|
|
|
|
|
|
1
|
|
Names of Reporting Persons
Jean-Pierre Sommadossi
|
2
|
|
Check the Appropriate Box
if a Member of a Group
(a) ☐ (b) ☐
|
3
|
|
SEC Use Only
|
4
|
|
Citizenship or Place of
Organization
United
States
|
|
|
|
|
|
|
|
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person
With
|
|
5
|
|
Sole Voting Power
1,174,999
|
|
6
|
|
Shared Voting Power
5,925,000
|
|
7
|
|
Sole Dispositive Power
1,174,999
|
|
8
|
|
Shared Dispositive Power
5,925,000
|
|
|
|
|
|
|
|
9
|
|
Aggregate Amount Beneficially Owned by Each Reporting Person
7,099,999
|
10
|
|
Check if the Aggregate
Amount in Row (9) Excludes Certain Shares
Not
Applicable
|
11
|
|
Percent of Class
Represented by Amount in Row 9
8.4%
|
12
|
|
Type of Reporting
Person
IN
|
|
|
|
|
|
CUSIP No. 04683R106
|
|
Schedule 13G
|
|
Page 3 of 6
|
ITEM 1.
|
(a) Name of Issuer:
|
Atea Pharmaceuticals, Inc. (the Issuer).
(b) Address of Issuers Principal Executive Offices:
125 Summer Street, Boston, MA 02110.
ITEM 2.
|
(a) Name of Person Filing:
|
Each of the following is hereinafter individually referred to as a Reporting Person and collectively as the
Reporting Persons. This statement is filed on behalf of:
JPM Partners LLC; and
Jean-Pierre Sommadossi
(b)
Address or Principal Business Office:
The business address of JPM Partners LLC is 2 Avery Street #21E, Boston, MA 02111.
The business address of Jean-Pierre Sommadossi is 125 Summer Street, Boston, MA 02110.
(c) Citizenship:
JPM
Partners LLC is a Delaware limited liability company. Dr. Sommadossi is a citizen of the United States.
(d) Title of Class of
Securities:
Common stock, par value $0.001 per share (Common Stock).
(e) CUSIP Number:
04683R106
Not applicable.
The ownership information below represents beneficial ownership of shares of Common Stock as of December 31, 2021, based upon 83,102,730
shares of Common Stock outstanding as of November 10, 2021, based on the Issuers Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on November 12, 2021.
(a-c)
|
|
|
|
|
CUSIP No. 04683R106
|
|
Schedule 13G
|
|
Page 4 of 6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reporting Person
|
|
Amount
beneficially
owned
|
|
|
Percent
of class:
|
|
|
Sole
power
to vote
or
to
direct
the
vote:
|
|
|
Shared
power to
vote or to
direct the
vote:
|
|
|
Sole
power to
dispose or
to direct
the
disposition
of:
|
|
|
Shared
power to
dispose or
to direct
the
disposition
of:
|
|
JPM Partners LLC
|
|
|
5,925,000
|
|
|
|
7.2
|
%
|
|
|
0
|
|
|
|
5,925,000
|
|
|
|
0
|
|
|
|
5,925,000
|
|
Jean-Pierre Sommadossi
|
|
|
7,099,999
|
|
|
|
8.4
|
%
|
|
|
1,174,999
|
|
|
|
5,925,000
|
|
|
|
1,174,999
|
|
|
|
5,925,000
|
|
JPM Partners LLC is the record holder of 5,925,000 shares of Common Stock. Dr. Sommadossi is the manager
of JPM Partners LLC and may be deemed to share beneficial ownership of the securities held by JPM Partner LLC. In addition, Dr. Sommadossi beneficially owns 1,174,999 shares of Common Stock subject to stock options that are currently
exercisable or will become exercisable within 60 days of December 31, 2021.
ITEM 5.
|
Ownership of Five Percent or Less of a Class.
|
Not applicable.
ITEM 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
Not applicable.
ITEM 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the
Parent Holding Company.
|
Not applicable.
ITEM 8.
|
Identification and Classification of Members of the Group.
|
Not applicable.
ITEM 9.
|
Notice of Dissolution of Group.
|
Not applicable.
Not applicable.
|
|
|
|
|
CUSIP No. 04683R106
|
|
Schedule 13G
|
|
Page 5 of 6
|
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true,
complete and correct.
Date: February 10, 2022
|
|
|
JPM Partners LLC
|
|
|
By:
|
|
/s/ Jean-Pierre Sommadossi
|
Name:
|
|
Jean-Pierre Sommadossi
|
Title:
|
|
Manager
|
|
Jean-Pierre Sommadossi
|
|
/s/ Jean-Pierre Sommadossi
|
|
|
|
|
|
|
CUSIP No. 04683R106
|
|
Schedule 13G
|
|
Page 6 of 6
|
LIST OF EXHIBITS
|
|
|
Exhibit No.
|
|
Description
|
|
|
99
|
|
Joint Filing Agreement (previously filed).
|
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Jul 2024 to Aug 2024
Atea Pharmaceuticals (NASDAQ:AVIR)
Historical Stock Chart
From Aug 2023 to Aug 2024